Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Am J Med
    December 2026
  1. BRAVO F, Moukabary T
    Blips and flips for quick identification of limb-lead reversal.
    Am J Med. 2026;139:e382-e385.
    >> Share

    October 2026
  2. HAYASHI H, Honda S, Kawasaki T
    Symptoms That Walk Away: The Walk-Through Phenomenon and Severe Coronary Artery Disease.
    Am J Med. 2026 Oct 30:S0002-9343(26)00780-1. doi: 10.1016/j.amjmed.2026.
    >> Share

  3. LOPEZ A, Haas MJ, Mooradian AD
    The Effects of Cannabinoids in Cardiovascular Disease: A Comprehensive Review.
    Am J Med. 2026 Oct 29:S0002-9343(26)00772-2. doi: 10.1016/j.amjmed.2026.
    >> Share

  4. SABOURET P, Giamundo DM, Asher E, De Rosa S, et al
    Pelacarsen and Lp(a)HORIZON: Interpreting the Disconnect Between Lipoprotein(a) Lowering and Cardiovascular Outcomes.
    Am J Med. 2026 Oct 15:S0002-9343(26)00749-7. doi: 10.1016/j.amjmed.2026.
    >> Share

  5. SULTAN S, Ahmed A, Nounu M, Sultan S, et al
    Microplastics and Nanoplastics as a Novel Cardiovascular Risk Factor: A Narrative Review.
    Am J Med. 2026 Oct 6:S0002-9343(26)00734-5. doi: 10.1016/j.amjmed.2026.
    >> Share

  6. GENOVESE C, Rizzo CE, Maisano D, Squeri R, et al
    Herpes Zoster as a Trigger of Cardiovascular Events: A Systematic Review of Epidemiological Evidence and Pathophysiological Mechanisms.
    Am J Med. 2026 Oct 4:S0002-9343(26)00737-0. doi: 10.1016/j.amjmed.2026.
    >> Share

  7. FAUCHIER L, Bouteau J, Genet T
    Crossing curves, uncertain effects: Spironolactone in heart failure with preserved ejection fraction after myocardial infarction.
    Am J Med. 2026;139:e292-e293.
    >> Share

  8. SULTAN S, Mahdi M, Ahmed A, Sultan S, et al
    Diet and Risk of Cardiovascular Disease.
    Am J Med. 2026 Oct 1:S0002-9343(26)00692-3. doi: 10.1016/j.amjmed.2026.
    >> Share

    September 2026
  9. LOI A, Fitzgerald PJ, Schanzer R, Singal D, et al
    Accelerated Specialty Entry (ASE): Redesigning the Pathway to Cardiovascular Specialty Appointments.
    Am J Med. 2026 Sep 30:S0002-9343(26)00687-X. doi: 10.1016/j.amjmed.2026.
    >> Share

  10. ZHENG H, Zhan H
    Telomeres in Aging: Links to Clonal Hematopoiesis, Cardiovascular Disease, and Cancer.
    Am J Med. 2026 Sep 29:S0002-9343(26)00694-7. doi: 10.1016/j.amjmed.2026.
    >> Share

  11. NAFAA F, Hure G, Kul S, Durak K, et al
    Diagnostic and prognostic value of growth differentiation factor 15 in suspected functionally relevant coronary artery disease.
    Am J Med. 2026 Sep 24:S0002-9343(26)00671-6. doi: 10.1016/j.amjmed.2026.
    >> Share

  12. FLEMING RM, Fleming MR
    Tire Wear Pollution and Cardiovascular Risk.
    Am J Med. 2026 Sep 17:S0002-9343(26)00651-0. doi: 10.1016/j.amjmed.2026.
    >> Share

    August 2026
  13. PARK MK, Causland FRM, Ravi KS
    Inflammation-Associated Cardiovascular Risk Differs According to SSRI Use in Patients with Chronic Kidney Disease.
    Am J Med. 2026 Aug 25:S0002-9343(26)00610-8. doi: 10.1016/j.amjmed.2026.
    >> Share

  14. CIRILLO P, Berteotti M, Galli M, Gargiulo G, et al
    Pretreatment with P2Y12 inhibitors in Acute and Chronic Coronary Syndromes: for whom, when and how.
    Am J Med. 2026 Aug 24:S0002-9343(26)00613-3. doi: 10.1016/j.amjmed.2026.
    >> Share

  15. HEO NJ, Han K, Lee KN, Jung JH, et al
    Impact of Low-density Lipoprotein Cholesterol Levels on Cardiovascular Risk in Chronic Kidney Disease: A Stage-specific Analysis.
    Am J Med. 2026 Aug 6:S0002-9343(26)00583-8. doi: 10.1016/j.amjmed.2026.
    >> Share

  16. HIGGINS JP
    Energy Drinks in Youth: Cardiovascular Risk and a Call to Action.
    Am J Med. 2026 Aug 5:S0002-9343(26)00596-6. doi: 10.1016/j.amjmed.2026.
    >> Share

  17. AHART Z, Becker RC
    Coronary Artery Calcium-Guided Antiplatelet Therapy: What Does the Evidence Show?
    Am J Med. 2026 Aug 1:S0002-9343(26)00579-6. doi: 10.1016/j.amjmed.2026.
    >> Share

    June 2026
  18. SULTAN S, Ahmed A, Obeidi Y, Mahdi M, et al
    Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.
    Am J Med. 2026 Jun 27:S0002-9343(26)00491-2. doi: 10.1016/j.amjmed.2026.
    >> Share

  19. LIM Y
    Night-Shift Intensity, Duration, Cardiovascular Susceptibility and Incident Cardiovascular Disease: UK Biobank Study.
    Am J Med. 2026 Jun 22:S0002-9343(26)00494-8. doi: 10.1016/j.amjmed.2026.
    >> Share

  20. AKINMOLAYEMI O, Oliva A, Santori S, Vasa D, et al
    Optimal Medical Therapy in Patients with Chronic Coronary Syndrome Undergoing PCI: Temporal Trends and Outcomes.
    Am J Med. 2026 Jun 8:S0002-9343(26)00450-X. doi: 10.1016/j.amjmed.2026.
    >> Share

    May 2026
  21. AVRAHAMI D, Zahger D, Arbel R, Rokach L, et al
    Effect of Cumulative Blood Pressure Exposure on Long-Term Cardiovascular Outcomes in the Community, a Nationwide Cohort Study.
    Am J Med. 2026 May 21:S0002-9343(26)00430-4. doi: 10.1016/j.amjmed.2026.
    >> Share

  22. VALERIANI E, Marcucci R, Di Nisio M, Calabro P, et al
    Age-related efficacy of aspirin in secondary prevention of coronary artery disease: START-ANTIPLATELET registry and meta-analysis of randomized trials.
    Am J Med. 2026 May 20:S0002-9343(26)00432-8. doi: 10.1016/j.amjmed.2026.
    >> Share

  23. NARDIN M, Mehran R, Oliva A, Kedhi E, et al
    From obesity to cardiovascular disease: pathological basis and clinical implications.
    Am J Med. 2026 May 7:S0002-9343(26)00382-7. doi: 10.1016/j.amjmed.2026.
    >> Share

  24. LI X, Wang S, Wang J, Ji Y, et al
    Circulating Apolipoprotein E concentration and incident cardiovascular diseases: evidence from an electronic health record-based cohort.
    Am J Med. 2026 May 6:S0002-9343(26)00376-1. doi: 10.1016/j.amjmed.2026.
    >> Share

  25. CHEON S, Choi YS, Kim YS, Chung JE, et al
    Bleeding-Related Interactions Between DOACs and Cardiovascular Drugs: Insights from FDA adverse event reporting system.
    Am J Med. 2026 May 5:S0002-9343(26)00388-8. doi: 10.1016/j.amjmed.2026.
    >> Share

  26. LAI JSY, Yeong N, Tan XY, Chen M, et al
    When troponin results lie: A narrative review and practical approach to spurious hypertroponinemia.
    Am J Med. 2026;139:626-633.
    >> Share

    April 2026
  27. OU YH, Colpani JT, Cheong CS, Loke W, et al
    Treatment of OSA using mandibular advancement versus CPAP in improving cardiovascular health.
    Am J Med. 2026 Apr 19:S0002-9343(26)00293-7. doi: 10.1016/j.amjmed.2026.
    >> Share

  28. KU L, Qiu R, Ma X
    Pheochromocytoma-Induced Angina Pectoris Mimicking Acute Coronary Syndrome.
    Am J Med. 2026 Apr 11:S0002-9343(26)00269-X. doi: 10.1016/j.amjmed.2026.
    >> Share

  29. ZHU L, Gu TS, Zhang YK, Hu ST, et al
    Efficacy of Spironolactone in Patients with Heart Failure with Preserved Ejection Fraction Following Acute Myocardial Infarction: A Multicenter Retrospective Cohort Analysis.
    Am J Med. 2026 Apr 7:S0002-9343(26)00272-X. doi: 10.1016/j.amjmed.2026.
    >> Share

  30. JAVADI N, Jan MF, Tajik AJ
    Auricular Nodule in 53-Year-Old Man with Subclinical Coronary Artery Disease.
    Am J Med. 2026 Apr 2:S0002-9343(26)00268-8. doi: 10.1016/j.amjmed.2026.
    >> Share

  31. MAGEN E, Merzon E, Magen I, Yakov A, et al
    Chronic Idiopathic Eosinopenia and Long-Term Cardiovascular Outcomes: A Population-Based Cohort Study.
    Am J Med. 2026 Apr 1:S0002-9343(26)00261-5. doi: 10.1016/j.amjmed.2026.
    >> Share

    March 2026
  32. ZHEUTLIN AR, Greenland P
    Coronary Artery Calcium Scoring: An Adjunct to Risk Stratification, Not a Replacement for It.
    Am J Med. 2026 Mar 20:S0002-9343(26)00208-1. doi: 10.1016/j.amjmed.2026.
    >> Share

  33. SCHADE DS, Blankenship J, Bouchonville M, Adolphe A, et al
    The Scientific Justification for Abandoning Risk Factor-based Guidelines for the Prevention of Atherosclerotic Cardiovascular Disease.
    Am J Med. 2026 Mar 19:S0002-9343(26)00218-4. doi: 10.1016/j.amjmed.2026.
    >> Share

  34. FAUCHIER L, Lenormand T, Lochon L, Bisson A, et al
    Reassessing the Association Between Celiac Disease and Cardiovascular Events: A Large Propensity-Matched Analysis from a Global Federated Research Network.
    Am J Med. 2026 Mar 9:S0002-9343(26)00147-6. doi: 10.1016/j.amjmed.2026.
    >> Share

  35. SCHADE DS, Adolphe A, Blankenship J, Eaton RP, et al
    Ten Reasons to Treat All Individuals with a Positive Coronary Artery Calcium Score.
    Am J Med. 2026 Mar 9:S0002-9343(26)00150-6. doi: 10.1016/j.amjmed.2026.
    >> Share

  36. AL-OBAIDI A, Pradhan M, Swarup S, Salem D, et al
    Socioeconomic Disadvantage and Cardiovascular Outcomes in Patients with Established Heart Disease: A Systematic Review.
    Am J Med. 2026 Mar 8:S0002-9343(26)00148-8. doi: 10.1016/j.amjmed.2026.
    >> Share

    February 2026
  37. SHAMSULDDIN AB
    Preventing stroke or myocardial infarction?: The new monotherapy crossroads in atrial fibrillation and coronary artery disease.
    Am J Med. 2026;139:e63-e64.
    >> Share

  38. ZHAI L, Teng D
    Beyond one-size-fits-all: The future of beta-blockers in coronary artery disease.
    Am J Med. 2026;139:e57-e58.
    >> Share

    January 2026
  39. FORMAN DE, Carey RM, Block S, Dentel S, et al
    Advancing Quality in Post-Acute Cardiovascular and Stroke Care: Why National Leadership and Certification Matter.
    Am J Med. 2026 Jan 30:S0002-9343(26)00058-6. doi: 10.1016/j.amjmed.2026.
    >> Share

  40. FORMAN DE, Carey RM, Block S, Dentel S, et al
    Post-Acute Cardiovascular and Stroke Care and the Potential of Certification Programs: A "Call to Action" Current Challenges of Post-Acute Care and Rationale for Certification.
    Am J Med. 2026 Jan 28:S0002-9343(26)00057-4. doi: 10.1016/j.amjmed.2026.
    >> Share

  41. FRISHMAN WH, Aronow WS, Alpert J
    Beta-Adrenergic Blockade in Survivors of Acute Myocardial Infarction: A half-century of Clinical rails and Therapeutic Recommendations.
    Am J Med. 2026 Jan 24:S0002-9343(26)00068-9. doi: 10.1016/j.amjmed.2026.
    >> Share

  42. WILLETT Y, Yang C, Dunn J, Benson K, et al
    Consumption of Ultra-Processed Foods and Increased Risks of Cardiovascular Disease in U.S. Adults.
    Am J Med. 2026 Jan 24:S0002-9343(26)00054-9. doi: 10.1016/j.amjmed.2026.
    >> Share

  43. MAGEN E, Aamar S, Merzon E, Rahamim E, et al
    Familial Mediterranean Fever and Long-Term Cardiovascular Disease Burden.
    Am J Med. 2026 Jan 9:S0002-9343(26)00020-3. doi: 10.1016/j.amjmed.2026.
    >> Share

    November 2025
  44. SCHADE DS, Blankenship JC, Adolphe A, Philip Eaton R, et al
    Cardiovascular Disease Risk Assessment from Circulating Lipid Particles - A New Challenge for Physicians.
    Am J Med. 2025 Nov 13:S0002-9343(25)00794-6. doi: 10.1016/j.amjmed.2025.
    >> Share

  45. GU E, Sharninghausen J, Pietz HL, Patel A, et al
    Diphenhydramine overdose in an older adult with neuropsychiatric and cardiovascular comorbidities: a case report.
    Am J Med. 2025 Nov 12:S0002-9343(25)00801-0. doi: 10.1016/j.amjmed.2025.
    >> Share

  46. REN M, Zhang J, Chi M
    Iron Supplementation May Become a New Option for the Treatment of Cardiovascular Disease.
    Am J Med. 2025;138:e245.
    >> Share

  47. LIAO Y, Liu S, Lv X
    A Broader Perspective on the Link Between Biological Aging and Cardiovascular Disease in Older Adults With Hypertension.
    Am J Med. 2025;138:e243.
    >> Share

    October 2025
  48. SCHADE DS, Blankenship JC, Gonzales K, Adolphe A, et al
    A New Paradigm to Reduce Cardiovascular Disease Based on the Pathogenesis of Atherosclerosis.
    Am J Med. 2025 Oct 16:S0002-9343(25)00700-4. doi: 10.1016/j.amjmed.2025.
    >> Share

    September 2025
  49. AHMED M, Rana JS, Ahmed R, Fonarow GC, et al
    Oral anticoagulant monotherapy in patients with chronic coronary disease: An updated meta-analysis.
    Am J Med. 2025 Sep 25:S0002-9343(25)00631-X. doi: 10.1016/j.amjmed.2025.
    >> Share

  50. GRINBERG T, Aviv Y, Shiyovich A, Vronsky D, et al
    Coronary Artery Disease Characterization and Plaque Morphology in Patients with Hypertrophic Cardiomyopathy.
    Am J Med. 2025 Sep 25:S0002-9343(25)00619-9. doi: 10.1016/j.amjmed.2025.
    >> Share

  51. AJMAL M, Javed A, Corban MT
    Cardiovascular Care in Rural America: Challenges, Insights, and Strategies for Meaningful Improvement.
    Am J Med. 2025 Sep 25:S0002-9343(25)00624-2. doi: 10.1016/j.amjmed.2025.
    >> Share

  52. KANG Y, Zhao Z, Yang Z, Zeng L, et al
    Beta-Blockers and Outcome in Patients with Suspected Coronary Artery Disease Evaluated Noninvasively.
    Am J Med. 2025;138:1257-1263.
    >> Share

  53. KADOSH S, Balkin N, Carasso S, Amsalem I, et al
    Reduced Left Ventricular Apical Rotation: A Novel Pathophysiological Correlate Underlining Acute Ischemic Mitral Regurgitation.
    Am J Med. 2025;138:1278-1284.
    >> Share

  54. JOLOBE OMP
    The Association of Spontaneous Coronary Artery Dissection and Myocardial Bridging.
    Am J Med. 2025;138:e191.
    >> Share

    August 2025
  55. LONNBERG F, Siddiqui AJ
    Risk of Cardiovascular Events in Patients Diagnosed with Venous Thromboembolism.
    Am J Med. 2025 Aug 29:S0002-9343(25)00560-1. doi: 10.1016/j.amjmed.2025.
    >> Share

  56. BABAR A
    Urgent Call for Targeted Interventions in Cardiovascular-Kidney-Metabolic Syndrome.
    Am J Med. 2025;138:e162.
    >> Share

    July 2025
  57. AJMAL M, Javed B, Kubba S, Singh K, et al
    Contemporary Review of Myocardial Bridging for Internists.
    Am J Med. 2025;138:1068-1073.
    >> Share

    June 2025
  58. ALKHALFAN F, Hariri E, Aggarwal A, Burton R, et al
    Impact of Atherosclerotic Conditions and Cardiovascular Medications on Abdominal Aortic Aneurysm Growth.
    Am J Med. 2025 Jun 25:S0002-9343(25)00408-5. doi: 10.1016/j.amjmed.2025.
    >> Share

  59. NHAT H, Ibrahim R, Mouhaffel R, Abdelnabi M, et al
    SGLT2 Inhibitors and Cardiovascular Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Real-World Retrospective Cohort Study.
    Am J Med. 2025 Jun 24:S0002-9343(25)00410-3. doi: 10.1016/j.amjmed.2025.
    >> Share

  60. JIANG Y, Zhang H, Zhang C, Geng Y, et al
    Impact of dual antiplatelet therapy duration on long-term outcomes following chronic total occlusion percutaneous coronary intervention.
    Am J Med. 2025 Jun 6:S0002-9343(25)00348-1. doi: 10.1016/j.amjmed.2025.
    >> Share

    May 2025
  61. FROOM P, Lellouche J, Shimoni Z
    TROPONIN TESTS IN PATIENTS ADMITTED TO INTERNAL MEDICINE DEPARTMENTS WITHOUT AN ACUTE CORONARY SYNDROME- LESS IS MORE.
    Am J Med. 2025 May 20:S0002-9343(25)00305-5. doi: 10.1016/j.amjmed.2025.
    >> Share

  62. OLA O, Knott JD, De Michieli L, Lobo R, et al
    Lack of Change in the Incidence of Unstable Angina after Transition to High-Sensitivity Cardiac Troponin T.
    Am J Med. 2025 May 18:S0002-9343(25)00304-3. doi: 10.1016/j.amjmed.2025.
    >> Share

  63. KU L, Yan Q, Deng W, Ma X, et al
    Right Coronary Artery Ulcerated Atheromatous Plaque.
    Am J Med. 2025 May 18:S0002-9343(25)00240-2. doi: 10.1016/j.amjmed.2025.
    >> Share

  64. TODUA I, Salem DN
    Cardioesophageal Reflex. Should It Trigger Clinician's Response?
    Am J Med. 2025;138:778-781.
    >> Share

    April 2025
  65. POLLMANN DL, Knott JD, Carvalho PEP, Apple FS, et al
    Cardiac biomarkers for the prediction, discrimination, and risk-stratification of type 2 myocardial infarction: a critical appraisal.
    Am J Med. 2025 Apr 26:S0002-9343(25)00239-6. doi: 10.1016/j.amjmed.2025.
    >> Share

  66. GELFMAN DM
    Colchicine in Coronary Artery Disease. When to Use?
    Am J Med. 2025 Apr 15:S0002-9343(25)00230-X. doi: 10.1016/j.amjmed.2025.
    >> Share

    March 2025
  67. RULI TM JR, Szarvas D, D'Amico A, Leesar M, et al
    A Case of Thyrotoxicosis-Induced Prinzmetal Angina Mimicking Acute ST-Elevation Myocardial Infarction.
    Am J Med. 2025 Mar 28:S0002-9343(25)00199-8. doi: 10.1016/j.amjmed.2025.
    >> Share

  68. MASINI G, Barsacchi M, Chiusolo S, Alberti M, et al
    Iron Deficiency in Acute Coronary Syndromes - Clinical Correlates and Outcomes.
    Am J Med. 2025 Mar 20:S0002-9343(25)00154-8. doi: 10.1016/j.amjmed.2025.
    >> Share

  69. LI L, A G, Guo Y, Liu H, et al
    Early beta-Blocker Use and Clinical Outcomes in Acute Myocardial Injury: A Retrospective Cohort Study.
    Am J Med. 2025 Mar 6:S0002-9343(25)00140-8. doi: 10.1016/j.amjmed.2025.
    >> Share

    February 2025
  70. JIN IT, Lee Y, Choi EY, Lee SH, et al
    Aspirin and clinical outcomes in individuals with incidentally diagnosed coronary artery stenosis.
    Am J Med. 2025 Feb 17:S0002-9343(25)00094-4. doi: 10.1016/j.amjmed.2025.
    >> Share

  71. LI X, Huo Y, Diao X, Liu Y, et al
    Prevalence and clinical significance of low QRS voltages in patients presenting for cardiovascular or related diseases.
    Am J Med. 2025 Feb 10:S0002-9343(25)00062-2. doi: 10.1016/j.amjmed.2025.
    >> Share

  72. KIM JE, Joo J, Kuku KO, Downie C, et al
    Prevalence, Disparities, and Mortality of Cardiovascular-Kidney-Metabolic Syndrome in US Adults, 2011-2018.
    Am J Med. 2025 Feb 3:S0002-9343(25)00063-4. doi: 10.1016/j.amjmed.2025.
    >> Share

    January 2025
  73. LIPPI G, Sanchis-Gomar F, Lavie CJ
    The recent (2018-2022) US monthly mortality for acute myocardial infarction still peaks in December and January.
    Am J Med. 2025 Jan 18:S0002-9343(25)00035-X. doi: 10.1016/j.amjmed.2025.
    >> Share

  74. ALPERT JS
    Perioperative Cardiovascular Management for Patients Undergoing Noncardiac Surgery: Guideline Updated.
    Am J Med. 2025 Jan 16:S0002-9343(24)00832-5. doi: 10.1016/j.amjmed.2024.
    >> Share

    December 2024
  75. MOVAHED MR, Irannejad K, Venard E, Keating L, et al
    Women with breast implants have higher adjusted abnormal cardiac testing and coronary angiography but lower coronary intervention.
    Am J Med. 2024 Dec 31:S0002-9343(24)00845-3. doi: 10.1016/j.amjmed.2024.
    >> Share

  76. SIEGEL J
    Aspirin guided by coronary artery calcium scoring for primary cardiovascular prevention in persons with subclinical coronary atherosclerosis.
    Am J Med. 2024 Dec 12:S0002-9343(24)00798-8. doi: 10.1016/j.amjmed.2024.
    >> Share

  77. YANG H, Luo L, Huang Z, Song Y, et al
    Association Between Patient and System Delays and In-Hospital Mortality in Primary PCI for STEMI: Findings from a Large, Nationwide Inpatients Sample.
    Am J Med. 2024;137:1227-1235.
    >> Share

    November 2024
  78. ABUGROUN A, Shah SJ, Fitzmaurice G, Hubbard C, et al
    The Association Between Accelerated Biological Aging and Cardiovascular Outcomes in Older Adults with Hypertension.
    Am J Med. 2024 Nov 12:S0002-9343(24)00702-2. doi: 10.1016/j.amjmed.2024.
    >> Share

  79. JEHLE DVK, Sunesra R, Uddin H, Paul KK, et al
    Benefits of Tadalafil and Sildenafil on Mortality, Cardiovascular Disease, and Dementia.
    Am J Med. 2024 Nov 10:S0002-9343(24)00705-8. doi: 10.1016/j.amjmed.2024.
    >> Share

  80. YAO Z, Gue Y, Lip GYH
    Comparison of Direct Oral Anticoagulants and Vitamin K Antagonists for Left Ventricular Thrombus: A Global Retrospective Study.
    Am J Med. 2024 Nov 8:S0002-9343(24)00703-4. doi: 10.1016/j.amjmed.2024.
    >> Share

  81. DRAVES J, Tekiner H, Yale SH, Yale ES, et al
    Cardiovascular Physical Examination in Internal Medicine Residents: Pause for Concern.
    Am J Med. 2024;137:e213-e214.
    >> Share

    October 2024
  82. FATUROS A, Wong M, Ghasemiesfe A, Amsterdam EA, et al
    SOCIODEMOGRAPHIC DISPARITIES IN CORONARY ARTERY CALCIUM SCREENING.
    Am J Med. 2024 Oct 16:S0002-9343(24)00643-0. doi: 10.1016/j.amjmed.2024.
    >> Share

  83. ABUHASIRA R, Burrack N, Turjeman A, Patt YS, et al
    Comparative Analysis of First-Line Antihypertensive Treatment Classes.
    Am J Med. 2024 Oct 16:S0002-9343(24)00645-4. doi: 10.1016/j.amjmed.2024.
    >> Share

  84. DE ALENCAR JN
    Data Concerns in Myocardial Infarction with Right Bundle Branch Block Study: A Closer Look at Methodological Issues.
    Am J Med. 2024;137:e197.
    >> Share

  85. GUIMARAES PO, Lopes RD, Wojdyla DM, Alexander JH, et al
    Antithrombotic Strategies According to Age: Insights from the AUGUSTUS Trial.
    Am J Med. 2024;137:958-965.
    >> Share

    September 2024
  86. TSAI MH, Chen YY, Liou HH, Wang JT, et al
    Febuxostat leads to better cardiovascular outcomes compared to allopurinol in patients with advanced chronic kidney disease: A Population-based Cohort Study.
    Am J Med. 2024 Sep 26:S0002-9343(24)00622-3. doi: 10.1016/j.amjmed.2024.
    >> Share

  87. KIM YJ, Malhi J, Trost J, Leucker T, et al
    A Case-Based Approach to the Management of Patients with Chronic Coronary Disease: Updates from the 2023 AHA/ACC Guidelines.
    Am J Med. 2024 Sep 14:S0002-9343(24)00576-X. doi: 10.1016/j.amjmed.2024.
    >> Share

  88. JORDA A, Pecho T, Horvath LC, Nishani E, et al
    Association of electrocardiogram findings with clinical outcomes in patients with chronic coronary syndrome: an analysis of the ISCHEMIA trials.
    Am J Med. 2024 Sep 14:S0002-9343(24)00572-2. doi: 10.1016/j.amjmed.2024.
    >> Share

    August 2024
  89. MADIAS JE
    Blood pressure/Heart Rate-Derived Ratios, as Indices of Health and Cardiovascular Pathology.
    Am J Med. 2024 Aug 10:S0002-9343(24)00492-3. doi: 10.1016/j.amjmed.2024.
    >> Share

  90. KIM J, Kang D, Park H, Park TK, et al
    Angiotensin receptor blockers versus angiotensin converting enzyme inhibitors in acute myocardial infarction without heart failure.
    Am J Med. 2024 Aug 3:S0002-9343(24)00477-7. doi: 10.1016/j.amjmed.2024.
    >> Share

  91. PALATNIC L, Kim JA, Kim SY, Moras E, et al
    Human Papillomavirus as Non-Traditional Cardiovascular Risk Factors: Fact or Fiction? Part 2.
    Am J Med. 2024 Aug 3:S0002-9343(24)00481-9. doi: 10.1016/j.amjmed.2024.
    >> Share

  92. LYAS C
    The Beneficial Effects of Fruits and Vegetables on Kidney Disease Progression and Cardiovascular Disease Risk.
    Am J Med. 2024 Aug 2:S0002-9343(24)00486-8. doi: 10.1016/j.amjmed.2024.
    >> Share

  93. GARCIA-VEGA D, Cinza-Sanjurjo S, Eiras S, Gonzalez-Juanatey JR, et al
    Combined Sodium-Glucose-Transporters Inhibitors and Glucagon-Like-Peptide Receptor Agonist Compared With Monotherapy Improves Long-Term Survival: A Real-World Registry.
    Am J Med. 2024;137:761-769.
    >> Share

  94. HONG B, Bea S, You SC, Chang Y, et al
    Comparative Effectiveness and Safety of Ticagrelor and Clopidogrel in Patients With or Without Chronic Liver Disease: A Nationwide Cohort Study.
    Am J Med. 2024;137:742-750.
    >> Share

  95. SHAH KS, Makaryus AN
    Navigating Diversity: Optimizing Data Collection for Cardiovascular Health.
    Am J Med. 2024 Aug 1:S0002-9343(24)00482-0. doi: 10.1016/j.amjmed.2024.
    >> Share

    July 2024
  96. EJIRI K, Mok Y, Ding N, Chang PP, et al
    Chest symptoms and long-term risk of incident cardiovascular disease.
    Am J Med. 2024 Jul 30:S0002-9343(24)00474-1. doi: 10.1016/j.amjmed.2024.
    >> Share

  97. GORAYA N, Madias NE, Simoni J, Kahlon M, et al
    Kidney and Cardiovascular Protection Using Dietary Acid Reduction in Primary Hypertension: A Five-Year, Interventional, Randomized, Control Trial.
    Am J Med. 2024 Jul 8:S0002-9343(24)00357-7. doi: 10.1016/j.amjmed.2024.
    >> Share

  98. ARSHAD F
    Breaking Barriers: Enhancing Statins Utilization for Cardiovascular Protection in MAFLD.
    Am J Med. 2024;137:e142.
    >> Share

    June 2024
  99. PALATNIC L, Kim JA, Kim SY, Moras E, et al
    Human Papillomavirus as Non-Traditional Cardiovascular Risk Factors: Fact or Fiction? Part 1.
    Am J Med. 2024 Jun 24:S0002-9343(24)00397-8. doi: 10.1016/j.amjmed.2024.
    >> Share

    May 2024
  100. LANG K, Chew C, De La Rosa M, Bertram AK, et al
    Performance of Cardiovascular Physical Exam Skills by Internal Medicine Residents.
    Am J Med. 2024 May 11:S0002-9343(24)00269-9. doi: 10.1016/j.amjmed.2024.
    >> Share

  101. SMATI H, Sellke FW, Bourque JM, Qadeer YK, et al
    Coronary Microvascular Dysfunction: A Guide for Clinicians.
    Am J Med. 2024 May 7:S0002-9343(24)00282-1. doi: 10.1016/j.amjmed.2024.
    >> Share

  102. KAWADA T
    Depression, Cardiovascular Disease, and Mortality.
    Am J Med. 2024;137:e96.
    >> Share

    April 2024
  103. SORENSEN NA, Fakhri Y, Gossling A, Neumann JT, et al
    Impact of quantitative ST-T analysis in patients with suspected myocardial infarction presenting with right bundle branch block.
    Am J Med. 2024 Apr 24:S0002-9343(24)00244-4. doi: 10.1016/j.amjmed.2024.
    >> Share

  104. VELASQUEZ GARCIA HA, Wong S, Jeong D, Binka M, et al
    Risk of major adverse cardiovascular events after SARS-CoV-2 infection in British Columbia: a population-based study.
    Am J Med. 2024 Apr 24:S0002-9343(24)00237-7. doi: 10.1016/j.amjmed.2024.
    >> Share

    March 2024
  105. HOWICK V JF, Saric P, Elwazir M, Newman DB, et al
    A Pragmatic Study of Cardiovascular Disease During Long-Term COVID-19.
    Am J Med. 2024 Mar 26:S0002-9343(24)00162-1. doi: 10.1016/j.amjmed.2024.
    >> Share

  106. ROOS A, Edgren G
    High-Sensitivity Cardiac Troponins in Patients with Chest Pain and Treatment With Oral Antineoplastic Agents Associated With Cardiovascular Toxicity.
    Am J Med. 2024 Mar 13:S0002-9343(24)00143-8. doi: 10.1016/j.amjmed.2024.
    >> Share

  107. FREUND O, Shetrit A, Bar-Shai A, Zornitzki L, et al
    Smoking and respiratory diseases in patients with coronary microvascular dysfunction.
    Am J Med. 2024 Mar 12:S0002-9343(24)00134-7. doi: 10.1016/j.amjmed.2024.
    >> Share

    February 2024
  108. HAMMOND MM, Cameron NA, Shah NS, Khan SS, et al
    An Age-Period-Cohort Analysis of Cardiovascular Disease Mortality in the United States from 1999 to 2018.
    Am J Med. 2024 Feb 22:S0002-9343(24)00108-6. doi: 10.1016/j.amjmed.2024.
    >> Share

    November 2023
  109. SCHADE DS, Hickey M, Eaton RP
    Interpreting the Coronary Artery Calcium Score - Critical Information for the Practicing Physician.
    Am J Med. 2023;136:1070-1075.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016